Add to ORKG© 2015 Khin et al.Background: Global malaria control efforts are threatened by the spread and emergence of artemisinin-resistant Plasmodium falciparum parasites. In 2012, the widespread sale of partial courses of artemisinin-based monotherapy was suspecte
Artemisinin-based combination therapy (ACT) is first-line treatment for Plasmodium falciparum malari...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...
Increasing access to artemisinin-based combination therapy (ACT) has played a key role in the recent...
BACKGROUND: In 2015/2016, an ACTwatch outlet survey was implemented to assess the anti-malarial and ...
BACKGROUND: The containment of artemisinin resistance in Myanmar, historically an important probable...
Abstract Background In 2015/2016, an ACTwatch outlet survey was implemented to assess the anti-malar...
BackgroundArtemisinin-based combination therapy (ACT) is a key strategy for global malaria eliminati...
BackgroundArtemisinin-based combination therapy (ACT) is a key strategy for global malaria eliminati...
BACKGROUND: In 2015/2016, an ACTwatch outlet survey was implemented to assess the anti-malarial and ...
BACKGROUND: The containment of artemisinin resistance in Myanmar, historically an important probable...
BACKGROUND: The aim of this paper is to review multi-country evidence of private sector adherence to...
© 2015 Aung et al.; licensee BioMed Central.Background: As efforts to contain artemisinin resistance...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...
Artemisinin-based combination therapy (ACT) is first-line treatment for Plasmodium falciparum malari...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...
Increasing access to artemisinin-based combination therapy (ACT) has played a key role in the recent...
BACKGROUND: In 2015/2016, an ACTwatch outlet survey was implemented to assess the anti-malarial and ...
BACKGROUND: The containment of artemisinin resistance in Myanmar, historically an important probable...
Abstract Background In 2015/2016, an ACTwatch outlet survey was implemented to assess the anti-malar...
BackgroundArtemisinin-based combination therapy (ACT) is a key strategy for global malaria eliminati...
BackgroundArtemisinin-based combination therapy (ACT) is a key strategy for global malaria eliminati...
BACKGROUND: In 2015/2016, an ACTwatch outlet survey was implemented to assess the anti-malarial and ...
BACKGROUND: The containment of artemisinin resistance in Myanmar, historically an important probable...
BACKGROUND: The aim of this paper is to review multi-country evidence of private sector adherence to...
© 2015 Aung et al.; licensee BioMed Central.Background: As efforts to contain artemisinin resistance...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...
Artemisinin-based combination therapy (ACT) is first-line treatment for Plasmodium falciparum malari...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...